-
摘要: [目的]探讨双歧三联活菌联合水飞蓟宾对非酒精性脂肪肝的疗效。[方法]选取2014年1月~2015年6月我院门诊非酒精性脂肪肝患者120例,随机分为观察组和对照组,观察组予双歧三联活菌散剂联合水飞蓟宾胶囊口服,对照组单独予水飞蓟宾胶囊口服,疗程12周,比较2组肝功能、血脂、肝脏CT评分。[结果]治疗组及对照组各项评分均较治疗前降低,差异有统计学意义(P＜0.05);2组比较,治疗组疗效优于对照组(P＜0.05)。[结论]双歧三联活菌联合水飞蓟宾胶囊对改善非酒精性脂肪肝患者肝功能、血脂及肝脏CT评分有显著临床疗效。
-
关键词:
- 益生菌水飞蓟宾双歧三联活菌非酒精性脂肪肝
-
-
[1] 戴鑫,吕宗舜.肠道屏障功能在非酒精性脂肪性肝病发病机制中的作用[J].世界华人消化杂志,2012,20(8):656-661.
[2] 曹毅,沈峰,徐雷鸣,等.肠道菌群和内毒素血症与非酒精性脂肪性肝病[J].实用肝脏病杂志,2012,15(12):163-165.
[3] FURRIE E.A molecular revolution in the study of intestinal microflora[J].Gut,2006,55:141-143.
[4] COMPARE D,CPCCOLI P,ROCCO A,et al.Guteliver axis:The impact of gut microbiota on nonalcoholic fatty liver disease[J].Nutr Metab Cardiovasc Dis,2012,22:471-473.
[5] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].中华肝病杂志,2010,18(8):163-166.
[6] FAN J G,FARRELL G C.Epidemiology of non-alcoholic fatty liver disease in China[J].J Hepatol,2009,50:204-210.
[7] ABU SHANAB A,QUIQLEY E M.The role of the gut microbiota in nonalcoholic fatty liver disease[J].Nat Rev Gastroenterol Hepatol,2010,7:691-701.
[8] IACONO A,RASO G M,CANANI R B,et al.Probioties as an emerging therapeutic strategy to treat NAFLD:focus on molecular and biochemical mechanisms[J].Nutr Biochem,2011,22:699-711.
[9] LIRUSSI F,MASTROPASQUA E,ORANDO S,et al.Probiotics for nonalcoholic fatty liver disease and/or steatohepatitis[J].Cochrane Data-base Syst Rev,2007,24:51-65.
[10] YIN L,LAEVSKY G,GIARDINA C.Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity[J].J Biol Chem,2001,276:44641-44646.
[11] POLYAK S J,OBERLIES N H,PECHEUR E I,et al.Silymarin for HCV infection[J].Antivir Ther,2013,18:141-147.
-
计量
- 文章访问数: 92
- PDF下载数: 119
- 施引文献: 0
下载: